Literature DB >> 23230898

Role of insulin resistance indices in predicting new-onset diabetes after kidney transplantation.

Pramod Nagaraja1, Vinod Ravindran, Gareth Morris-Stiff, Kesh Baboolal.   

Abstract

New-onset diabetes mellitus (NODAT) is a serious complication following renal transplantation. In this cohort study, we studied 118 nondiabetic renal transplant recipients to examine whether indices of insulin resistance and secretion calculated before transplantation and at 3 months post-transplantation are associated with the development of NODAT within 1 year. We also analysed the long-term impact of early diagnosed NODAT. Insulin indices were calculated using homeostasis model assessment (HOMA) and McAuley's Index. NODAT was diagnosed using fasting plasma glucose. Median follow-up was 11 years. The cumulative incidence of NODAT at 1 year was 37%. By logistic regression, recipient age (per year) was the only significant pretransplant predictor of NODAT (OR 1.04, CI 1.009-1.072), while age (OR 1.04, CI 1.005-1.084) and impaired fasting glucose (OR 2.97, CI 1.009-8.733) were significant predictors at 3 months. Pretransplant and 3-month insulin resistance and secretion indices did not predict NODAT. All-cause mortality was significantly higher in recipients developing NODAT within 1 year compared with those remaining nondiabetic (44% vs. 22%, log-rank P = 0.008). By Cox's regression analysis, age (HR 1.075, CI 1.042-1.110), 1-year creatinine (HR 1.007, CI 1.004-1.010) and NODAT within 3 months (HR 2.4, CI 1.2-4.9) were independent predictors of death. In conclusion, NODAT developing early after renal transplantation was associated with poor long-term patient survival. Insulin indices calculated pretransplantation using HOMA and McAuley's Index did not predict NODAT.
© 2012 The Authors Transplant International © 2012 European Society for Organ Transplantation. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23230898     DOI: 10.1111/tri.12026

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  12 in total

Review 1.  Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management.

Authors:  David Langsford; Karen Dwyer
Journal:  World J Diabetes       Date:  2015-08-25

2.  Genetics of new-onset diabetes after transplantation.

Authors:  Jennifer A McCaughan; Amy Jayne McKnight; Alexander P Maxwell
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

3.  Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Authors:  Manfred Hecking; Johannes Werzowa; Michael Haidinger; Walter H Hörl; Julio Pascual; Klemens Budde; Fu L Luan; Akinlolu Ojo; Aiko P J de Vries; Esteban Porrini; Giovanni Pacini; Friedrich K Port; Adnan Sharif; Marcus D Säemann
Journal:  Nephrol Dial Transplant       Date:  2013-01-17       Impact factor: 5.992

Review 4.  Diabetes Mellitus Following Renal Transplantation: Clinical and Pharmacological Considerations for the Elderly Patient.

Authors:  David Langsford; Adam Steinberg; Karen M Dwyer
Journal:  Drugs Aging       Date:  2017-08       Impact factor: 4.271

5.  New onset diabetes after transplantation: Not another acronym!

Authors:  I R Wallace; N H Waters; H Pilmore; P L Drury; F Wu
Journal:  JRSM Open       Date:  2015-03-02

6.  A Prospective Study of Renal Transplant Recipients: A Fall in Insulin Secretion Underpins Dysglycemia After Renal Transplantation.

Authors:  David Langsford; Varuni Obeyesekere; Sara Vogrin; Jessie Teng; Richard J MacIsaac; Glenn Ward; Frank Alford; Karen M Dwyer
Journal:  Transplant Direct       Date:  2016-10-07

7.  Conversion to sirolimus therapy in kidney transplant recipients with new onset diabetes mellitus after transplantation.

Authors:  Massimiliano Veroux; Tiziano Tallarita; Daniela Corona; Nunziata Sinagra; Alessia Giaquinta; Domenico Zerbo; Carmela Guerrieri; Antonino D'Assoro; Sebastiano Cimino; Pierfrancesco Veroux
Journal:  Clin Dev Immunol       Date:  2013-05-20

8.  mTOR Inhibition: Reduced Insulin Secretion and Sensitivity in a Rat Model of Metabolic Syndrome.

Authors:  Jordi Rovira; María Jose Ramírez-Bajo; Elisenda Banon-Maneus; Daniel Moya-Rull; Pedro Ventura-Aguiar; Natalia Hierro-Garcia; Marta Lazo-Rodriguez; Ignacio Revuelta; Armando Torres; Federico Oppenheimer; Josep M Campistol; Fritz Diekmann
Journal:  Transplant Direct       Date:  2016-01-22

9.  Sirolimus induces depletion of intracellular calcium stores and mitochondrial dysfunction in pancreatic beta cells.

Authors:  Angela Lombardi; Jessica Gambardella; Xue-Liang Du; Daniela Sorriento; Maurizio Mauro; Guido Iaccarino; Bruno Trimarco; Gaetano Santulli
Journal:  Sci Rep       Date:  2017-11-20       Impact factor: 4.379

10.  An observational Prospective Study to Evaluate the Preoperative Risk Factors of New-onset Diabetes Mellitus after Renal Transplantation in a Tertiary Care Centre in Eastern India.

Authors:  Santosh Kumar; Debmalya Sanyal; Pratik Das; Kingshuk Bhattacharjee; Rohit Rungta
Journal:  Indian J Endocrinol Metab       Date:  2018 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.